The EMA has progressively restarted the activities related to Policy 0070 for centrally authorised medicinal products for human use.
Have a look at this timeline that Asphalion experts have prepared for you to take into consideration the steps and timing regarding clinical data publication for new MAA. At the same time, you can also discover Asphalion’s expertise on the 0070 Policy linked to EMA milestones.
Watch the document here: TRANSPARENCY POLICY 0070
Reach out to us now to be ready for policy 0070 and learn how Asphalion can help you!
Contact us at: [email protected]